No Data
Amex: First quarter report 2025
Express News | Imeik Technology Q1 Net Profit Down 15.9% Y/Y
Estimating The Fair Value Of Imeik Technology Development Co.,Ltd. (SZSE:300896)
Imeik Technology Development (300896.SZ): The acquisition of the controlling stake in South Korea's REGEN Biotech, Inc. has completed the necessary approvals from domestic government departments.
On April 8th, Gelonghui reported that Imeik Technology Development (300896.SZ) announced that concerning the acquisition of controlling interest in South Korea's REGEN Biotech, Inc., as of April 7, 2025, this investment matter has received the project filing notice number Jing Fa Gai (Bei) [2025] 187 issued by the Peking Development and Reform Commission, has obtained the Overseas Investment Certificate No. N1100202500204 issued by the Peking Bureau of Commerce, and has received approval from the Forex Administration Bureau Peking Branch.
Imeik Technology Development Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Imeik Technology Development (300896.SZ) 2024 annual report released: Revenue breaks 3 billion for the first time, significant dividends returned to investors.
On the evening of March 19, 2025, Imeik Technology Development (300896.SZ) released the 2024 annual report, with both revenue and profit reaching historical highs.
Imeik Technology Development Co.,Ltd.'s (SZSE:300896) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
, you can go to trade A share there apply and just take 5-10min approve